Use and reporting of patient-reported outcomes in randomized controlled trials in non-Hodgkin lymphoma: a scoping review

Abstract Background Non-Hodgkin lymphoma (NHL) constitutes a biologically and clinically heterogeneous group of lymphoid malignancies, with varying prognoses and treatment aims between indolent and aggressive subtypes. While survival outcomes remain key efficacy measures, they insufficiently capture...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Julia Schroer, Paul Jan Bröckelmann, Sam Salek, Tatyana Ionova, Edward Laane, Esther Natalie Oliva, Ina Monsef, Nicole Skoetz, Mario Csenar
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	SpringerOpen 2026-01-01
Serie:	Journal of Patient-Reported Outcomes
Soggetti:	Non-Hodgkin lymphoma Patient-reported outcomes Patient-reported experience PRO instrument Quality of life Scoping review
Accesso online:	https://doi.org/10.1186/s41687-026-00999-1
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!